Eating behavior in patients with metabolically associated fatty liver disease

Abstract

The purpose of this study was to study the phenotypes of eating behavior in patients with NAFLD and their determining factors. Discussion: fatty liver disease has a high prevalence (24-26%) with an upward trend in both developed and developing countries, and in the coming years may become one of the main causes of liver transplantation. The clinical features of the disease are in most cases its asymptomatic course, which can progress to fibrosis/cirrhosis and is associated with the risk of a number of serious extrahepatic diseases (cardiovascular, oncological and others). The mechanisms underlying the formation of increased health risks and disease prognosis are multifactorial. Metabolic disorders, orthorexia nervosa, eating disorders and vegetative effects are considered as possible pathogenetic mechanisms for increasing the risk of NAFLD incidence. Conclusion: the study showed that complex behavioral psycho-social factors are involved in the pathogenesis of NAFLD, and changing eating behavior is an important component of therapy. Dysfunctional eating behavior can be a barrier to long-term success from therapy.